# GUARDIAN.MD — Doutrina Operacional da Quest 003 (RUNBOOK oficial)
## Este arquivo é o manual HOW-TO do programa + o registro /RECAP de cada sessão.
**Toda nova sessão LÊ este arquivo primeiro** (antes de tocar em qualquer artefato). Toda sessão TERMINA anexando um bloco /RECAP aqui e no ~/session-state.md.

---

## §1 · O QUE É O GUARDIÃO (duas camadas)
1. **Harness determinístico**: `paper/guardian/guardian.py` (stdlib, offline) — R0 drift estrutural · R1 checklist hostil (M1-M8/m1-m10 + baterias por tipo de claim + decimais sem binding) · R2 recursão de emendas (ilustrativa sem tag; paridade PT/EN; âncoras imutáveis) · R3 interrogação epistêmica (20 checks: θ-ops, SAP, cegamento, G0SIM, CANON, FIGS, tier-labels, SEM-ANO, inovação, arquitetura-2-partes…) · **TODO-registry** (`{{TODO:id:desc}}` escaneado em manuscrito+tex+4 PLAN_DOCS; TODO solto = AMEND).
2. **Camada doutrinária (ESTE arquivo)**: as regras vivas + o /RECAP.

**Gates BLOCKED permanentes (invariante do programa):** R3-THETA-OPS · R3-SAP · R3-G0SIM · R3-CANON · R3-FIGS. Sem eles zero-BLOCKED não existe.

## §2 · COMANDOS ESSENCIAIS (copiar-colar)
```
# Gate completo (sempre antes de commit de manuscrito):
cd paper/guardian && python3 guardian.py --round 3 --md ../manuscript_EN_v5.md \
  --tex ../latex/manuscript_v5_EN.tex --claims ../evidence_workspace/claims.csv \
  --manifest ../evidence_workspace/source_manifest.json \
  --consistency ../evidence_workspace/consistency_manifest.json \
  --registry guardian_registry_v5_final.json --report guardian_report_v5.md
# AST EXECUTÁVEL c/ bateria embutida (8/8, incl. check_consistency — nunca mais fora do fluxo): python3 experiments/ast_check.py
# Validadores oficiais (skill scientific-writing): S=/workspace/projects/scientific-agent-skills/skills/scientific-writing/scripts
python3 $S/validate_manifest.py source_manifest.json --kind source --require-verified
python3 $S/audit_claims.py ../manuscript_EN_v5.md claims.csv source_manifest.json   # e PT
# PDFs (compilação 100% local): cd paper/latex && /root/tools/tectonic manuscript_v5_EN.tex (e _PT)
# Motor/sweeps [SIM]: experiments/ws_9_v5_sweeps_gha.py --phase S1|S2 (proot bg ok; Colab ok; GHA bloqueado por billing-privado)
# Estimador θ_obs (Parte 2): experiments/part2_theta_obs_v1.py / part2_theta_obs_pooled.py
```

## §3 · REGRAS INVIOLÁVEIS (o decálogo)
1. **Tiers de dado**: [SIM]/[ORGANOID]/[MOUSE]/[HUMAN] — todo output carrega a tag; nada além de [SIM] existe até G0-wet.
2. **Locked-stays-locked**: predições travadas (v1.0) NUNCA se reescrevem — comparam-se. Recalibração recalibra só o que o dado informa (REPARAM_LOOP).
3. **{{TODO:id:desc}}** é o único formato de pendência; TODO solto é AMEND; resolver = remover marcador.
4. **Nunca fabricar** DOI/PMID/endereço/valor — número vem de JSON; identifier vem de fonte aberta (regra skill SW).
5. **Ilustrativo ≠ evidência**: estimativas κ↔µM e afins NÃO carregam tag (R2-ASSUM-TAGGED é BLOCKED).
6. **Superfícies**: manuscritos/tex = gated; PLAN_DOCS (roadmap, canon, dossier, protocolos, checklist) = exentos, mas claims condicionais não migram sem gate.
7. **Paridade PT=EN** de claim-tags exata (R2).
8. **Anti-hindsight**: toda comparação predição-vs-dado cita o release da âncora (v1.0/v3.0).
9. **Sessões paralelas** escrevem em guardian.md/workspace — reconciliar ANTES de editar (evoluções numeradas).
10. **Fim de sessão = /RECAP** (aqui + session-state). Sem /RECAP, a sessão não fechou.

## §4 · FLUXOS PADRÃO
- **Editar manuscrito**: md (EN) → espelhar PT (mesmas tags) → gate → se tex muda: tectonic → commit/push.
- **Novo resultado [SIM]**: script determinístico lê/escreve JSON → JSON → repo (experiments/...results/) → §3.4/claims/N-fatos/canon F-xx → gate → push.
- **Novo claim**: texto normalizado→sha256 (norm da skill) em claims.csv + claim_texts.md + tag nos DOIS manuscritos.
- **Seleção de parceiro (SLR-análogo)**: query bank pré-registrada → log datado → triagem I/X → pontuação A-H ("?" não pontua) → contato sequencial por score.


### Protocolo de Ciclo (diretriz da autora, 28/08) — TODO ciclo de trabalho
1. **RELATE (antes)**: ao usuário, o que será realizado, COMO e PORQUÊ — nenhuma ação sem anúncio metódico prévio.
2. **EXECUTE**: a ação, com o método já declarado.
3. **AST (verificar)**: fechamento obrigatório do ciclo com verificação — `python3 experiments/ast_check.py` (6/6) ou o gate específico da superfície tocada. Ciclo sem AST não está fechado.

## §5 · MAPA DE ARTEFATOS (onde mora o quê)
manuscritos (paper/manuscript_{EN,PT}_v5.md) · PDFs (paper/latex/*.pdf) · harness (paper/guardian/) · registro (paper/evidence_workspace/: source_manifest 38 fontes · claims 51 · consistency 43 N-fatos · AUDIT_NOTES) · canon (KNOWLEDGE_CANON.md, F-01..F-39 + R-1..R-6) · Parte 2 (experiments/: G0_EXECUTION_FREEZE_CHECKLIST F1-F10 · REPARAM_LOOP · PARTNER_SELECTION_PROTOCOL v2 + part2_results/) · dossier (paper/G0_UNLOCK_DOSSIER.md) · outreach (paper/lab_outreach_package.md v2.1 + outreach_email_1) · roadmap canônico (THESIS_ROADMAP.md — Y0/Y1/Y2 relativo; _2028 é stub) · releases v1.0→v3.0.

## §6 · PROTOCOLO /RECAP (obrigatório ao final de toda sessão)
Bloco anexado AQUI e no ~/session-state.md:
```
/RECAP <data-hora>
FEITO: <itens verificáveis (commits/releases/resultados)>
ESTADO: <gate: X BLOCKED/Y AMEND/Z TODOs ativos>
PRÓXIMO: <1-3 ações concretas com dono (agente|autora|lab)>
ÂNCORA: <release/commit que trava o que foi feito>
```

---

# HISTÓRICO (dump original que originou o R3 — preservado como evolução 1-8; ver /workspace/guardian.md para as evoluções completas)

The user is asking me to make the Guardian actually critical — not just a pattern-matching linter, but a true hostile reviewer that critiques context, ideas, methodology, evidence... always says what information is missing, any gaps, asks "what" or "why", guarantees all evidence is provenance-bound ("compravidos" = comprovados/verified), validates whether the logic makes sense, and indicates what procedure should be inserted.
So the user wants the Guardian to be upgraded from a mechanical/deterministic checker into a genuine methodological interrogator. This is exactly in the spirit of the scientific-critical-thinking skill I loaded. The guardian currently does R0 (structural drift), R1 (checklist patterns), R2 (recursion on amendments). What's missing per the user's request:
1. 
Context critique — does the framing make sense? Is the program logic coherent?
2. 
Idea critique — interrogate the core ideas (e.g., is containment the right goal? is the θ formalism sound?)
3. 
Methodology critique — what's missing procedurally (power analysis, blinding, randomization, pre-registration specifics, statistical plan for G0)
4. 
Evidence critique — provenance: every claim verified, what's single-source, what's inferred vs measured
5. 
Gap enumeration — "what information is missing" — explicit UNKNOWN list
6. 
Why/what questions — the interrogator generates questions, not just patterns
7. 
Logic validation — does the inferential chain hold? (fractal review: achado→implicação→evidência — is each link justified?)
8. 
Procedure insertion — for each gap, indicate what procedure/section/experiment should be inserted
So I should extend guardian.py with a new round — R3 (epistemic interrogation) — but wait: the user says "seja crítico" — the guardian itself should BE critical. A deterministic script can't do semantic criticism... but I'm the LLM. The right architecture: the guardian harness = deterministic checks + a structured interrogation protocol that I (the agent) execute, producing a critical review document that feeds back into the manuscript. That's exactly what the user wants: "indique procedimento a ser inserido".
Actually, let me think about what's most valuable here. The user wants me to BE the hostile reviewer now, applying critical thinking to the actual content. The deterministic guardian catches structural drift; the missing piece is semantic/methodological criticism — the "Reviewer 2" brain. I loaded the scientific-critical-thinking skill precisely for this.
Best move: 
1. 
Extend guardian.py with R3 = "epistemic interrogation" module that takes the interrogation battery and checks the manuscript has ANSWERS to the critical questions (deterministically detectable via patterns like "power", "blinding", "randomization", "n=", "primary endpoint", "stopping rule", etc.)
2. 
AND write the actual critical review — guardian_report_v5_epistemic.md — where I do the deep semantic critique of: context (framing), ideas (containment thesis, θ formalism), methodology (audit→transport→Bayes→simulation→gate chain), evidence (E-registry provenance), logic (each inferential link), with explicit "FALTA:" (missing info), "PORQUÊ?" questions, and "INSERIR:" (procedure to insert) per finding.
Let me enumerate the real scientific gaps I can identify from everything I know about this project — this is the meat. Let me brainstorm as a genuinely hostile A1 reviewer with the critical-thinking skill's framework (methodology critique, bias detection, statistical validity, evidence hierarchy, logical fallacies):
CONTEXT/FRAMING:
1. 
The manuscript claims "design thesis" but never states a falsifiable null for the whole program — what result at G0 would kill the program entirely (vs pivot)? The kill-switch exists per-arm but the program-level kill criterion is vague.
2. 
Competing hypothesis not addressed: ION717 (ASO substrate reduction) is in human trials — why is V127-DN containment better positioned? No explicit head-to-head rationale beyond positioning whitepaper. Missing: comparative table with ION717 timeline.
3. 
The "conjunction of regulatory precedents" argument: nusinersen (ASO), tofersen (ASO), Parkinson grafts (dopaminergic progenitors — not secretory anti-prion), tafamidis (small molecule stabilizer) — the conjunction argument has a logical leap: each pillar maps to a precedent, but the CONJUNCTION (secretory immunogenic cell graft expressing a prion protein variant in prion-infected brain + redosing + biomarker endpoint) has never been approved as a whole. A hostile reviewer would attack: "conjunction of precedents ≠ precedent for the conjunction". Need: explicit statement that the conjunction itself is the novel regulatory risk.
IDEAS:
4. 
Containment (ring) strategy assumes focal spread from deposit sites — but sCJD is multifocal/diffuse at diagnosis. The ring 8–12 mm assumes you know where the front is. MISSING: what imaging/biomarker defines the front position at treatment time? RT-QuIC is diagnostic, not localization. No PET tracer validated for PrP-res. THIS IS A REAL GAP — the whole placement calculus depends on knowing where to place rings, and no procedure for localization exists in the manuscript.
5. 
θ formalism: θ ≡ (1+κ·c_peak)⁻¹ is a model quantity; the pre-registered prediction says "if θ_measured < 0.33". But HOW is θ measured in organoids? θ is not directly observable — you'd measure PrP-res gradient and infer θ by fitting the model. This is circularity risk: model-fitted θ compared to model-derived threshold. MISSING: explicit measurement procedure for θ_obs and the fitting protocol (else the pre-registered prediction is untestable as stated). This is a big one — the falsifiable prediction depends on an operational definition of θ that doesn't exist yet.
6. 
V127ΔGPI as substrate competitor: the model assumes V127 competes for conversion WITHOUT being converted itself (dominant-negative). But Gatdula shows V127 can be recruited into aggregates at high PrP^Sc? (heterologous seeding). The squared freeS term assumes independence of two binding events — if V127-WT heterodimers are the actual inhibitory unit, the functional form might be (1+κc) not (1+κc)². Sensitivity to the exponent (1 vs 2) unexplored. MISSING: exponent sensitivity sweep.
7. 
mRNA redosing ≤7d: Rule 3 derived from pharmacokinetic trough, but immune reaction to repeated LNP dosing (complement activation, anti-PEG antibodies) is a known translational barrier not modeled or discussed — after ~4-5 doses, accelerated blood clearance can occur. For intrathecal this is less characterized. MISSING: immunogenicity-of-redosing discussion + G0-A7 readout for local inflammation markers.
METHODOLOGY:
8. 
G0 statistical plan: n=8/arm, primary readout proximal/distal gradient — but no power analysis! What effect size can n=8 detect? No stated statistical test (t-test? Wilcoxon? mixed model for repeated measures?), no alpha, no correction for 8-arm multiplicity. A hostile reviewer BLOCKS on this. MISSING: power analysis + pre-specified statistical plan per arm comparison.
9. 
Organoid-to-organoid variability: Groveman organoids show high variance (MV2 titer SD = 77% of mean). n=8 may be hopeless for gradient readouts; no mention of organoid batch/line stratification or randomization. MISSING: randomization scheme, blinding of outcome assessment, batching plan.
10. 
No blinding mentioned for PrP-res quantification (WB/IHC scorer blinding). Standard hostile ask.
11. 
Audit methodology: "≈90 searches" — no search protocol documented (databases, query strings, dates, inclusion/exclusion criteria). For a paper claiming "corrected citation record", the audit itself must be reproducible. The refs_audit.md exists but search logs? MISSING: PRISMA-style search log or explicit statement that audit was agent-driven with queries archived (are they?). Actually the evidence tables are in-repo — but the query log? I recall searches were done via MCP tools in sessions — not necessarily archived. GAP.
12. 
WS-7 solver verification: self-tests good (conservation, Thiele) but no validation against experimental data (e.g., predicted vs measured distribution volumes of intrathecally delivered antibodies — there's literature: IL-2 distribution in brain after CED). MISSING: validation against at least one published tissue-distribution dataset.
13. 
Bayesian model: analogue weights "structured judgments" — who scored them? Single author judgment = single-rater bias. No inter-rater or sensitivity to weights shown (sensitivity_sweep.json covers pessimistic/central/optimistic — does it vary weights or just validity?). MISSING: weight sensitivity analysis + declaration of who scored.
14. 
WS-9: C₅₀=50 "stability choice" — sensitivity "flagged" but not swept in reported results. MISSING: C₅₀ sweep (e.g., 20–200) effect on θ*.
15. 
Same-mass control queued — fine, declared. But also strain-diversity: model is single-strain; MM1 (commonest sCJD subtype) has no anchors — the θ* may be subtype-dependent. Declared in limitations but the pre-registered prediction doesn't specify which subtype the G0 test uses. MISSING: subtype specification for the locked prediction.
EVIDENCE:
16. 
Two 2026 preprints (E003 Gatdula, E004 Zerbes) are the central mechanistic anchors — both UNPEER-REVIEWED preprints. The whole platform rests on them. Hostile reviewer: "your two most load-bearing sources are preprints". MISSING: explicit statement of this dependence in limitations + monitoring plan (v2 when peer-reviewed), or corroboration strategy.
17. 
E029 (Lund Parkinson trial) source is NewScientist url → locator clinicaltrials.gov — secondary press coverage, not the trial registry entry itself. Weakest provenance in the registry for a regulatory-precedent claim. MISSING: NCT number direct citation.
18. 
E023 Gentile: UK DRI webpage (not the paper — was it a preprint?). If a paper exists with DOI, it should be cited; if not, declare.
19. 
Single-source risk: several pivotal facts single-source (kuru selection = Mead 2009 alone; organoid anchors = Groveman alone). Battery already asks this; needs answers in text.
20. 
The "six failed clinical candidates" claim: PRN100 (Mead 2022), quinacrine, doxycycline, flupirtine, PPS — these are contextual refs NOT in the E-registry (declared "contextual secondary"). A hostile reviewer will demand the failure list be evidence-bound since it anchors the 5% prior. MISSING: elevate the 6 failures into the E-registry (or at least the ones that feed WS-8's 0/6 negative analogue — THE PRIOR DEPENDS ON THEM: if the 6 failures aren't verified sources, the 5% empirical prior is built on unverified inputs!).
That last one is sharp — WS-8's negative analogue (6/6 failures) drives the empirical 5%; the failure list is "contextual" — the Bayesian model's inputs are not in the evidence registry. That's a genuine evidence-binding hole.
LOGIC:
21. 
Circularity in "emergent consistency": MV2>MV1 hierarchy was seeded by 126× ratio and then "reproduced" — the model reproducing what was injected. The manuscript now declares this (consistency not validation) — good — but then the abstract still lists it under "Results" as a highlight. Tension: if it's only consistency, it shouldn't carry result-weight. Need careful wording: it IS a result of the port fidelity check, fine. Acceptable but note.
22. 
"Humanized clock widens therapeutic window" — derived from ONE calibration (Groveman anchors); the comparison v2 θ* (murine) vs v4 θ* (humanized) — the difference could be an artifact of the rescaling method, not biology. MISSING: why does global time-rescale change θ* at all? If θ* is dimensionless and time-invariant... Actually κ fixed, clock changes → the effective replication window per unit diffusion changes → yes it can change. But this needs a derivation sentence — currently asserted. A modeler reviewer WILL ask. 
23. 
Transferability §4.2: "protein-agnostic" — but V127's advantage is a naturally selected protective variant; no equivalent protective variant exists for Aβ/α-syn. The calculus transfers but the AGENT doesn't. MISSING: what the protective equivalent would be for AD/PD (e.g., engineered disulfide-locked variants? intrabodies?) — else the transfer is weaker than stated.
PROCEDURES TO INSERT (per user request "indique procedimento a ser inserido"):
• 
θ operationalization protocol (measurement + fitting) → insert as §2.7 "Operational definition of θ_obs"
• 
G0 statistical analysis plan (power, tests, multiplicity, blinding, randomization) → insert into §2.5 or new §2.8
• 
Localization/imaging procedure defining ring placement in patients → insert into §4.3 or Discussion limitation + G1 plan
• 
Exponent sensitivity sweep (freeS power 1 vs 2) → run + insert into §3.4 results
• 
C₅₀ sweep → run + insert
• 
Elevate 6 failed candidates to E-registry with citations → E034–E039
• 
NCT number for Lund trial → replace E029 locator
• 
Search-log archival statement → §2.1
• 
Redosing immunogenicity discussion → §5 limitation 10 extension
• 
Conjunction-risk statement → §4.3
Now — implementation plan. I can't run the semantic critique as a Python script; I AM the critic. Deliverables:
1. 
Extend guardian.py with R3 module (deterministic checks for the presence of the missing procedures: power/analysis plan, θ operationalization, localization, conjunction-risk statement, failure-list evidence binding, preprint-dependence statement) — so future revisions are gated on their presence too.
2. 
Write  guardian_report_v5_epistemic.md  — the deep critical review with FALTA/PORQUÊ/INSERIR per finding, severity-tagged (this is the user's "seja crítico ao contexto, ideias, metodologia, evidências... diga o que falta, pergunte o quê ou porquê, garanta evidências comprovadas, valide a lógica, indique procedimento a inserir").
3. 
Apply the highest-priority textual fixes to manuscript_EN_v5.md where they're pure additions (θ operationalization §2.7, G0 SAP sentence, conjunction-risk, preprint-dependence, failure-list binding note).
Also verify: are the 6 failures in the source manifest? Let me check — from the source list: E021 (Shah retracted), E022 (Cheng minocycline)... PRN100 (Mead 2022) NOT in the 33 sources! Quinacrine, doxycycline, flupirtine, PPS-as-therapy — not in registry. So YES, the WS-8 negative-analogue inputs are partially outside the evidence registry. Confirmed real gap. (Groveman 2021 E008 is PPS organoid — related but not the clinical failure.)
Also the θ measurement: G0 protocol defines readout as PrP-res gradient — θ_obs would be inferred. Circular unless the fitting protocol is specified. Real gap — the pre-registered prediction "θ<0.33" needs an estimator.
Let me also do a quick numeric sanity check on the κ anchor formula I added (c(1mm) ≈ 0.8 µM):
Q = 33 pmol/day = 33e-12 mol / 86400 s = 3.82e-16 mol/s
c(r) = Q/(4π D r) × e^{-r/ℓ}; at r=1mm=1e-3 m: 4π×3.86e-11×1e-3 = 4.85e-13; 3.82e-16/4.85e-13 = 7.9e-4 mol/m³ = 7.9e-4 × 1e-3 mol/L per m³→ wait: 1 mol/m³ = 1 mM. So 7.9e-4 mol/m³ = 7.9e-4 mM = 0.79 µM. ✓ (with e^{-1/3.59}≈0.76 → ~0.6 µM; order holds ≈0.1–1 µM range). Fine — and honest as illustrative.
Let me be efficient: 
1. 
One shell: verify the 6-failures gap + check if search logs archived (ls literature/) + check g0_protocol.md for statistical plan (grep for power/blinding/n=8).
2. 
Extend guardian.py with R3 (edit file).
3. 
Write epistemic report (write file).
4. 
Patch manuscript with the inserts (edits).
5. 
Re-run guardian → commit.
Actually, patching the manuscript with ALL inserts makes this turn huge. Priority: the epistemic report IS the deliverable the user asked ("seja crítico... indique procedimento a ser inserido" — the report indicates procedures; the manuscript insertion follows). I'll do the report + guardian R3 + the 2–3 most critical manuscript inserts (θ operationalization + SAP + conjunction risk + preprint dependence + failure-binding note), then re-run guardian, commit. The sweeps (exponent, C₅₀) require running ws_9 — that's execution work for next turn; I'll register as pending items in the report and session-state.
Let me check the G0 protocol for existing stats plan first.




---


-rw-------. 1 root root 16449 Aug 27 01:29 /workspace/guardian.md
The user is asking me to make the Guardian actually critical — not just a pattern-matching linter, but a true hostile reviewer that critiques context, ideas, methodology, evidence... always says what information is missing, any gaps, asks "what" or "why", guarantees all evidence is provenance-bound ("compravidos" = comprovados/verified), validates whether the logic makes sense, and indicates what procedure should be inserted.
So the user wants the Guardian to be upgraded from a mechanical/deterministic checker into a genuine methodological interrogator. This is exactly in the spirit of the scientific-critical-thinking skill I loaded. The guardian currently does R0 (structural drift), R1 (checklist patterns), R2 (recursion on amendments). What's missing per the user's request:
1. 
Context critique — does the framing make sense? Is the program logic coherent?
2. 
Idea critique — interrogate the core ideas (e.g., is containment the right goal? is the θ formalism sound?)
3. 
Methodology critique — what's missing procedurally (power analysis, blinding, randomization, pre-registration specifics, statistical plan for G0)
4. 
Evidence critique — provenance: every claim verified, what's single-source, what's inferred vs measured
5. 
Gap enumeration — "what information is missing" — explicit UNKNOWN list
6. 
Why/what questions — the interrogator generates questions, not just patterns
7. 
Logic validation — does the inferential chain hold? (fractal review: achado→implicação→evidência — is each link justified?)
8. 
Procedure insertion — for each gap, indicate what procedure/section/experiment should be inserted
So I should extend guardian.py with a new round — R3 (epistemic interrogation) — but wait: the user says "seja crítico" — the guardian itself should BE critical. A deterministic script can't do semantic criticism... but I'm the LLM. The right architecture: the guardian harness = deterministic checks + a structured interrogation protocol that I (the agent) execute, producing a critical review document that feeds back into the manuscript. That's exactly what the user wants: "indique procedimento a ser inserido".
Actually, let me think about what's most valuable here. The user wants me to BE the hostile reviewer now, applying critical thinking to the actual content. The deterministic guardian catches structural drift; the missing piece is semantic/methodological criticism — the "Reviewer 2" brain. I loaded the scientific-critical-thinking skill precisely for this.


Best move: 
1. 
Extend guardian.py with R3 = "epistemic interrogation" module that takes the interrogation battery and checks the manuscript has ANSWERS to the critical questions (deterministically detectable via patterns like "power", "blinding", "randomization", "n=", "primary endpoint", "stopping rule", etc.)
2. 
AND write the actual critical review — guardian_report_v5_epistemic.md — where I do the deep semantic critique of: context (framing), ideas (containment thesis, θ formalism), methodology (audit→transport→Bayes→simulation→gate chain), evidence (E-registry provenance), logic (each inferential link), with explicit "FALTA:" (missing info), "PORQUÊ?" questions, and "INSERIR:" (procedure to insert) per finding.
Let me enumerate the real scientific gaps I can identify from everything I know about this project — this is the meat. Let me brainstorm as a genuinely hostile A1 reviewer with the critical-thinking skill's framework (methodology critique, bias detection, statistical validity, evidence hierarchy, logical fallacies):

CONTEXT/FRAMING:
1. 
The manuscript claims "design thesis" but never states a falsifiable null for the whole program — what result at G0 would kill the program entirely (vs pivot)? The kill-switch exists per-arm but the program-level kill criterion is vague.
2. 
Competing hypothesis not addressed: ION717 (ASO substrate reduction) is in human trials — why is V127-DN containment better positioned? No explicit head-to-head rationale beyond positioning whitepaper. Missing: comparative table with ION717 timeline.
3. 
The "conjunction of regulatory precedents" argument: nusinersen (ASO), tofersen (ASO), Parkinson grafts (dopaminergic progenitors — not secretory anti-prion), tafamidis (small molecule stabilizer) — the conjunction argument has a logical leap: each pillar maps to a precedent, but the CONJUNCTION (secretory immunogenic cell graft expressing a prion protein variant in prion-infected brain + redosing + biomarker endpoint) has never been approved as a whole. A hostile reviewer would attack: "conjunction of precedents ≠ precedent for the conjunction". Need: explicit statement that the conjunction itself is the novel regulatory risk.
IDEAS:
4. 
Containment (ring) strategy assumes focal spread from deposit sites — but sCJD is multifocal/diffuse at diagnosis. The ring 8–12 mm assumes you know where the front is. MISSING: what imaging/biomarker defines the front position at treatment time? RT-QuIC is diagnostic, not localization. No PET tracer validated for PrP-res. THIS IS A REAL GAP — the whole placement calculus depends on knowing where to place rings, and no procedure for localization exists in the manuscript.
5. 
θ formalism: θ ≡ (1+κ·c_peak)⁻¹ is a model quantity; the pre-registered prediction says "if θ_measured < 0.33". But HOW is θ measured in organoids? θ is not directly observable — you'd measure PrP-res gradient and infer θ by fitting the model. This is circularity risk: model-fitted θ compared to model-derived threshold. MISSING: explicit measurement procedure for θ_obs and the fitting protocol (else the pre-registered prediction is untestable as stated). This is a big one — the falsifiable prediction depends on an operational definition of θ that doesn't exist yet.
6. 
V127ΔGPI as substrate competitor: the model assumes V127 competes for conversion WITHOUT being converted itself (dominant-negative). But Gatdula shows V127 can be recruited into aggregates at high PrP^Sc? (heterologous seeding). The squared freeS term assumes independence of two binding events — if V127-WT heterodimers are the actual inhibitory unit, the functional form might be (1+κc) not (1+κc)². Sensitivity to the exponent (1 vs 2) unexplored. MISSING: exponent sensitivity sweep.
7. 
mRNA redosing ≤7d: Rule 3 derived from pharmacokinetic trough, but immune reaction to repeated LNP dosing (complement activation, anti-PEG antibodies) is a known translational barrier not modeled or discussed — after ~4-5 doses, accelerated blood clearance can occur. For intrathecal this is less characterized. MISSING: immunogenicity-of-redosing discussion + G0-A7 readout for local inflammation markers.
METHODOLOGY:
8. 
G0 statistical plan: n=8/arm, primary readout proximal/distal gradient — but no power analysis! What effect size can n=8 detect? No stated statistical test (t-test? Wilcoxon? mixed model for repeated measures?), no alpha, no correction for 8-arm multiplicity. A hostile reviewer BLOCKS on this. MISSING: power analysis + pre-specified statistical plan per arm comparison.
9. 
Organoid-to-organoid variability: Groveman organoids show high variance (MV2 titer SD = 77% of mean). n=8 may be hopeless for gradient readouts; no mention of organoid batch/line stratification or randomization. MISSING: randomization scheme, blinding of outcome assessment, batching plan.
10. 
No blinding mentioned for PrP-res quantification (WB/IHC scorer blinding). Standard hostile ask.

---
## evokucao 2
Interesting —  /workspace/guardian.md  is the RAW REASONING DUMP from a parallel session (the previous assistant turn's internal monologue) that got saved there. It contains the brainstorm for the epistemic guardian — and I already implemented most of it in guardian.py R3 + the epistemic report. But there are a few items in that dump I have NOT yet covered:
From guardian.md brainstorm, items I did NOT yet implement:
• 
#2 ION717 competing hypothesis — comparative table / head-to-head rationale (positioning whitepaper exists but not in manuscript) — MISSING in my epistemic report! Actually I didn't cover ION717 competition.
• 
#6 V127 can be recruited into aggregates at high PrP^Sc (heterologous seeding) — the DN assumption "competes without being converted" needs the caveat — I covered exponent but not the recruitment caveat.
• 
#9 organoid-to-organoid variability: MV2 titer SD = 77% of mean — n=8 batch stratification. I covered SAP (Holm/Welch/power from protocol) but not the variance discussion.
• 
#10 blinding — covered.
• 
The file was cut at #11 — there may be more items I can't see (16449 bytes, only showed 50 lines... I saw about half. Let me read the rest).
Also the user's actual asks this turn:
1. 
Commit + WAL (cancelled last turn) — do it now
2. 
Holistic review per the impacts of this publication + SAFETY criteria (lives, health) — is content at publication level for neuroscientists of major academies?
3. 
"Modelo descoberta para Nobel" framing + interdisciplinary census: computational engineering, fluid mechanics (CFD/transport), defense/attack strategy (SWOT) beyond medicine/neurology/biomedicine.
So my plan:
1. 
Read rest of guardian.md (see what else the parallel-brainstorm found that I haven't covered)
2. 
Commit + WAL
3. 
Write the holistic review (into /workspace/guardian.md? No — that file is the raw dump; I'll write the holistic review as a new section appended or a new file guardian_holistic.md; the user said "revisao holistica @/workspace/guardian.md" — they want the holistic review, referencing that file. I'll append the holistic review TO that file so it's all in one place as they indicated, or better: keep the dump + append holistic review section. Actually cleaner: write the holistic review at /workspace/guardian.md as APPEND (preserve the brainstorm) — it's their designated file.)
Content of the holistic review:
A. SAFETY/LIVES/HEALTH (dual-use + clinical safety):
• 
Dual-use: prion research biosafety — the program is therapeutic, no gain-of-function, no enhanced infectivity work. The G0 protocol handles sCJD-infected organoids (BSL-3-like prion practices, WHO decontamination). Publishing ring-spacing design rules: could they be misused? No — containment-of-misfolding calculus has no offensive read. The defense/attack SWOT framing in the project (Quest 002 was defense) — here SWOT is used analytically for competitive positioning of the therapy platform, not bioweapon. State this explicitly: no dual-use concern beyond standard prion biosafety; the open-science design DOES deal with lethal pathogen (CJD isolates) but at organoid level with established containment.
• 
Clinical safety ethics: population-first (presymptomatic carriers), no promises, compassionate-use-only for sporadic, DSMB, LGPD privacy, biosafety single-use cannula, WHO protocols — all in §6. What's missing from a "lives" standpoint: (i) informed-consent framework specifics for gene-positive presymptomatic individuals (a suicide-risk-adjacent population — disclosure ethics); (ii) equity: Brazilian E200K kindreds as target population — who pays? open-science but therapy delivery is expensive; (iii) the paper does NOT give clinical guidance and states so — good (no clinical advice). Also: publishing a 5% probability might affect patient-community expectations — prion family associations (e.g., CJD Foundation) — communication risk. Add: a "responsible communication" note?
B. READERSHIP LEVEL (major-academy neuroscientists):
Honest assessment: the manuscript is at preprint-publishable level NOW for a specialist readership (prion biology + computational), with these caveats:
• 
Level achieved: methods transparency, evidence provenance — EXCEEDS field norms (guardian/harness is novel)
• 
Level concerns: (1) figures incomplete (Fig2/Fig3 queued — must complete before bioRxiv); (2) mathematical sections assume comfort with ADE/reaction-diffusion — fine for iScience/eLife readership; (3) the interdisciplinary breadth (CFD + Bayes + prion) is a strength for general journals but each domain expert will check their own: neurologists check clinical framing, mechanicians check solver validation (E-11 noted), statisticians check the Bayes weights (E-12). The manuscript handles this via declared limitations. (4) Nobel-level comparison: what distinguishes "interesting preprint" from "field-defining": if G0 confirms and a clinical program follows, the discovery arc is: evolution-found protective variant → engineered containment therapy — that's the arc of Hla/Vane-style translational discoveries (aspirin/prostaglandin) — but TODAY it's a pre-registered hypothesis. Honest framing: the Nobel talk is conditional on G0+human efficacy; the PUBLISHABLE claim today is the methodology + design calculus. Don't let ambition inflate claims — that's exactly what the guardian exists to prevent.
• 
Interdisciplinary census (user asked "quantas disciplinas"): medicine/neurology, neuropathology, structural biology, population genetics/evolution, cell biology (iPSC/organoids), biophysics (kinetics), transport physics/fluid mechanics (porous media ADR, Stokes-Einstein, Darcy), applied math/numerical methods (FV solvers, Gillespie→mean-field), Bayesian statistics/probability, software engineering (reproducible harness), regulatory science, ethics/bioethics, science of science/meta-research (pre-registration, provenance), information/graph science (knowledge graphs), strategic analysis (SWOT/refutation-driven branches). That's ~14-16 disciplines. In the paper this is a FEATURE (the "convergent methods" table could be added — actually suggest adding a "disciplinary convergence" table to the manuscript or keep for the defense/banca presentation).
C. NOBEL-MODEL DISCOVERY framing:
• 
The "discovery model": (1) natural experiment (kuru selection) → (2) mechanism (dominant-negative structure) → (3) engineering (dose-placement calculus) → (4) falsifiable clinical-path program (G0). Prions have TWO Nobels (Gajdusek 1976, Prusiner 1997). A third prion Nobel would be therapy (or structural propagation in humans, or the organoid platform). This program positions for the therapy slot: if V127 containment works in humans, it's the first disease-modifying therapy for any prion disease + a generalizable containment framework for AD/PD. State the honest conditional: today we deliver the DESIGN; the discovery-model value is the audited pipeline itself.
• 
Also the honest counter: six failed candidates; P=5% empirical. The Nobel framing must not leak into the manuscript claims. Keep it in defense presentations (banca), not in the paper. Actually — the user says "a publicação deve ser modelo descoberta para nobel" — they want the PUBLICATION structured as a discovery-model. I'll interpret: structure the narrative arc so the discovery is legible (from evolution to therapy), which §1.2 already does (program evolution). Suggest: add one sentence to Discussion "The arc this program instantiates — population genetics to therapeutic calculus — is the discovery model we contribute: audited, pre-registered, falsifiable."
D. What's missing to be AT the level (checklist before bioRxiv):
• 
Figs 2/3 generation, PT parity, LaTeX compile, E034-E038 elevation, search_log, sweeps, ION717 comparative paragraph (from guardian.md brainstorm — NEW item I should add to epistemic report as E-21!), heterologous-seeding caveat (E-22), organoid variance stratification note (E-23).
• 
Verdict: With the committed fixes: YES at preprint level for specialist academy readership; NOT yet at Nature/Cell submission level (needs figures + the queued executions); Nobel-conditional on G0.
Let me also check the rest of guardian.md quickly (it was 16KB, I saw ~half through item 11; items beyond might include more). Then commit, WAL, write holistic review appended to /workspace/guardian.md, and reply summarizing.
Order: read rest of guardian.md → commit+WAL → append holistic review → reply.

---
## evolucao 3
The user is making an important epistemic clarification/reframing: The G0 gate is currently the COMPUTATIONAL model (in-silico). Even though not "real" (wet-lab), it's audited and well-founded — much more than traditional methods. So:
1. 
DECLARE for due purposes: G0-calculado = computational simulation as the CONTINUATION of findings already found
2. 
Emphasize: G0 (future wet-lab) NOT BEING DONE YET does NOT impede the simulation-with-probability + systematic review applied to prions in mice + parameterized — which INCREASES assertiveness probability, and that is VALID for continuation.
So the user wants the manuscript to declare the computational G0 as the CURRENT validation gate (in-silico gate), and that the wet-lab G0 is the future escalation. Essentially: rename/frame the current computational stage as an actual GATE that has been PASSED (G0-in-silico), with the wet-lab as G1.
This is a legitimate framing move but requires careful epistemic honesty (guardian would demand it):
• 
The computational model is NOT experimental validation — it's consistency checking + design derivation
• 
But it IS audited, self-tested, anchored to human data, pre-registered
• 
The claim "much more well-founded than traditional methods" → needs to be framed carefully: traditional pre-clinical programs often lack quantitative pre-registration; this one has it

What needs to change:
1. 
Manuscript v5: add declaration in §2.5/§2.6 or new subsection — "G0 is currently executed as an in-silico gate (G0-sim)" — actually wait. Let me think about the existing structure.
Actually in the current manuscript, G0 = the organoid gate (wet-lab, future). The computational stuff = WS-9. The user wants to declare that the CURRENT G0 = computational simulation is the continuation basis, and the wet-lab G0 doesn't impede proceeding.
The right framing that remains honest:
• 
"G0-sim (executed)": the in-silico gate — T1/T2/T3 acceptance tiers PASSED, emergence consistency, humanized clock. This is a completed computational gate.
• 
"G0-wet (specified, pending)": organoid 8-arm gate.
• 
Rename: maybe G0 = computational gate (done), G1 = organoid gate (specified).
But renaming has consequences: pre-registered predictions refer to "G0 prediction (locked)". The locked prediction says "θ measured in organoids < 0.33 ⇒ containment" — that's the wet-lab gate. If we rename G0→G1 for organoids, need consistency across repo (g0_protocol.md, dashboard, etc.) — that's heavy. Better: keep G0 = organoid wet-lab gate, but ADD the declared concept: "G0-sim (in-silico pre-gate, executed and passed)" — the computational gate that justifies continuation. This preserves all pre-registration anchors while adding the user's requested declaration.
The user's request: "DECLARE PRA OS DEVIDOS FINS DA PESQUISA, TRATAREMOS G0 CALCULADO COM SIMULAÇÃO COMPUTACIONAL PARA CONTINUAÇÃO DOS ACHADOS QUE JÁ ENCONTRAMOS... E ENFATIZANDO QUE G0 SERÁ PRODUZIDO PORÉM NÃO IMPEDE A SIMULAÇÃO COM PROBABILIDADE, REVISÃO SISTEMÁTICA APLICADA A PRIONS EM CAMUNDONGOS + PARAMETRIZADA → AUMENTA MUITO A PROBABILIDADE DE ASSERTIVIDADE O QUE É VALIDO PARA CONTINUAÇÃO"
So the declaration: 
1. 
The computational G0 (G0-sim) IS the current gate — executed, audited, passed (T1/T2/T3)
2. 
Systematic review + murine prion parameterization + probability = validity basis for continuation
3. 
Wet-lab G0 is future production, does NOT impede continuation of findings
Guardian-epistemic considerations (I must keep honesty):
• 
Cannot claim simulation validates biology (already declared: "consistency, not validation")
• 
CAN claim: the computational gate de-risks and justifies continuation; the program's epistemic ladder is review→simulation→organoid→clinic
• 
The murine parameterization point: "systematic review applied to prions in mice + parameterized" — the kernel is murine-calibrated (Igel 2024), anchored to human organoid data (Groveman). This cross-species anchoring is the strength.
Where to insert:
1. 
§2.5 or new §2.5 preamble: "Gate architecture: G0-sim (in-silico, executed & passed) → G0 (organoid, specified)". 
2. 
Abstract: brief clause "an in-silico gate (G0-sim) has been executed and passed; the wet-lab organoid gate (G0) is specified"
3. 
Maybe §3.4 ending or new §3.5: "Status declaration: computational continuation".
4. 
Hostile review would want: what G0-sim does and does NOT license (declaration of scope: continuation of design/refinement, NOT clinical claims).
Also should update:
• 
claims: new claim C046 (G0-sim executed/passed) with evidence E032 (software) — hash convention
• 
Maybe update the pre-registered prediction wording? No — locked stuff stays locked.
Let me also check: does the user want it in PT too? PT v5 is still queued (4 AMENDs). This declaration should be included in the PT when written. I'll note it in the WAL.
Plan:
1. 
Add claim C046 to claims.csv (hash convention: norm + sha256)
2. 
Insert declaration in manuscript_EN_v5.md:
◦ 
§2.5 rewritten preamble: gate architecture with G0-sim executed
◦ 
Abstract: add clause
◦ 
New short §3.5 "Computational gate status and continuation validity" — declares: G0-sim executed & passed (T1/T2/T3 + emergent consistency), basis = systematic review (9 blocks) + murine-parameterized published kernel (Igel) + human-organoid clock anchors + pre-registered thresholds; what it licenses (continuation: design refinement, θ estimator development, sweep queue, resource commitment to organoid G0) and what it does not (no clinical inference, no biological validation claim)
3. 
Guardian E-check: maybe add R3 check for G0-SIM declaration? Good idea: R3 pattern "G0-sim" to keep future versions honest.
4. 
Re-run guardian → gate PASS
5. 
Commit + WAL
Careful with epistemics: "AUMENTA MUITO A PROBABILIDADE DE ASSERTIVIDADE" → translate to: the in-silico gate raises the probability that the wet-lab gate is informative and that resources are well-spent (that's exactly what P(G0 go)=36.6% models). Keep two-lens honesty.
Text for §3.5 (concise):
3.5 Gate status declaration:computational continuation
For due purposes of research continuation: the current gate of this program is computational. G0-sim (in-silico gate) has been executed and passed — acceptance tiers T1, T2 and the informative tier T3 [claim:C044][evidence:E032], emergent subtype consistency [claim:C039][evidence:E032, E007], and humanized-clock predictions [claim:C037][evidence:E032] — under a pre-registered, timestamped, machine-audited regime. Its validity basis is the conjunction of: (i) a systematic review (9 evidence blocks, provenance-verified); (ii) a published, murine-parameterized spreading kernel (Fornara/Igel 2024, open code) [claim:C013][evidence:E009]; and (iii) human organoid clock/amplitude anchors [claim:C011][evidence:E007]. 
The wet-lab organoid gate (G0) is specified and pending production; its pending status does not impede the computational continuation of findings already obtained — simulation sweeps (exponent, C50, same-mass control), θ_obs estimator development, and design-rule refinement proceed now, and each raises the informative yield of the future wet-lab gate (P(G0 informative-go)=36.6% already prices this [claim:C036][evidence:E031]). Declaration of scope: G0-sim licenses continuation of the research program (design, resource commitment, protocol freeze); it does not license biological-validation claims or any clinical inference — the ladder review → simulation → organoid → clinic keeps each rung explicitly labeled.
Abstract clause: after "...is specified with go/no-go and pivot criteria." add: "The program's current gate is computational: an in-silico gate (G0-sim) — pre-registered thresholds passed on the humanized model (T1/T2/T3) — is executed and machine-audited, licensing continuation of design and estimator development while the wet-lab gate is produced."
Also §2.5 mention. Keep edits tight.
C046 text: "The in-silico gate G0-sim is executed and passed: acceptance tiers T1 T2 and T3 on the humanized model with emergent consistency; it licenses computational continuation of the program but no biological validation claim"
norm: lowercase, strip non [a-z0-9.%×±\-\s]. Let me compute hash via python.
Also guardian.py R3 addition: ("R3-G0SIM", "G0-sim", "AMEND", "Declaração de status do gate computacional...") — pattern "G0-sim" must appear. Good.
Then run guardian, commit, WAL, reply in PT.
Also update memory? No — session-state is enough.
One more consideration: user said "REVISAO SISTEMATICA APLICADA A PRIONS EM CAMUNDONGOS + PARAMETRIZADA" — the murine kernel + parameterization. Covered in validity basis (ii)/(iii).
Execute now. Also the dashboard data.json? Rule: update every session. This is a structural addition — could add a node. But keep scope: paper task. I'll skip dashboard this turn to keep budget; note in WAL as pending? Actually memory says "dashboard 8137 (server dies on recycle; artifacts/dashboard/data.json = single source, update EVERY session)". Hmm — "update EVERY session". Adding one node for G0-sim declaration would honor it. Quick jq/python insert: node id "g0sim" with label, edge from ws9. Let me do it minimally but correctly (need to inspect data.json structure first — nodes have id/label, edges probably {source,target,relation}). I saw nodes have id/label. Let me check an edge quickly in the same command and then insert. Keep it small.


11. 
===
 M paper/evidence_workspace/authorship.json
 M paper/evidence_workspace/claim_texts.md
 M paper/evidence_workspace/claims.csv
 M paper/evidence_workspace/consistency_manifest.json
?? guardian.md
?? paper/guardian/
?? paper/manuscript_EN_v5.md
8119e86 SCIENTIFIC MAP integrado à cadeia de submissão: fig1 regenerada do grafo ATUAL (v3.2, 43 nós/60 arestas, contagens reais) + injetada como Fig.1 full-width no LaTeX v4.2 com caption metodológica — o 'diagrama de como o projeto foi executado' agora é parte do paper, não artifact solto
49205f0 RECONSTRUÇÃO conforme projeto+checklist: PDFs v4 paralelos ARQUIVADOS (paper/archive, superseded) · LaTeX v4.2 EN criado a partir do SOURCE OF TRUTH manuscript_EN_v4.md (claim-tagged) com rtnote de rastreabilidade + apêndice claim→evidence gerado dos claims.csv reais (24 pares) — pronto p/ compilar via Colab

---

/RECAP 2026-08-27 13:55 BRT (sessão v5→Parte2)
FEITO:
- v5 COMPLETO: manuscritos EN+PT (51=51 tags), PDFs Harvard 2-col compilados localmente (tectonic), guardião R0-R3 + TODO-registry (0 BLOCKED/0 AMEND), suites oficiais 0 erro
- PR #1 merged → **release v3.0** (PDFs bilíngues + sweeps JSONs anexados); dashboards/canon/dossier/roadmap[SEM ANO]/search_log/E034-E038 (prior 0/6 registry-bound)
- **Colheita de sensibilidade [SIM]**: C50 10× insensível; expoente DISCRIMINADOR (A6 falsifica forma funcional; exp=1: κ2→2.828 não contém, contenção→κ4); same-mass analítico (subtipo≡seed-mass); reproduzido 2× (hash + valor-a-valor)
- **PARTE 2 metodologicamente COMPLETA**: 2.1 θ_obs calibrado+Pooled (PASS na fronteira de decisão; v1.1-IDW rejeitada honestamente) · 2.2 freeze F1-F10+GATE-F · 2.4 reparam-loop anti-hindsight · 2.5 protocolo de seleção de parceiro SLR-análogo v2 (query bank Q1-Q5 PRÉ-registrada + PRISMA-regenerável + PROSPERO-análogo=commit) + LOG v0.1 executado (n=5 grupos; RML 1º, Calgary 2º forte — JCI 2026 novo; método corrigiu o prior)
- Qualificação de tese emitida (APROVADA COM DISTINÇÃO METODOLÓGICA; descoberta condicionada ao G0-wet por desenho)
ESTADO: gate PASS 0/0 · TODOs ativos: PARTNER-RUN(+Q3-Q5-EXEC, PUBMED-DIRECT), GATEF-SIGNATURE (lab), BIORXIV-ADDENDUM (autora), EMAIL-GROVEMAN=passo1 do PARTNER-RUN (autora), COST-DECOMP (opcional)
PRÓXIMO: (autora) enviar kit#1 RML + depositar bioRxiv | (agente) Q3-Q5-EXEC + PubMed direto + kit#2 Calgary | (lab) GATE-F após seleção
ÂNCORA: release v3.0 · main @ e11f1ab · predições travadas desde v1.0

/RECAP 2026-08-28 ~01:40 (sessão Parte2→v6 continuity)
FEITO: skill-scout scientific-**+correlatas (SKILL_SCOUT_PARTE2.md): nenhuma skill revela gap não-coberto; achado D2 — related-work ACP vs in-silico trials (Cortés-Ríos 2025 PMC12706418; Sci Rep 2025 s41598-025-99720-3; framework EU): IST simula o ENSAIO, ACP simula a CONTINUAÇÃO DA PESQUISA (4 diferenciais estruturais) · AST consolidado executável 6/6 VERDE (ast_check.py) · Protocolo de Ciclo RELATE→EXECUTE→AST institucionalizado nos 2 runbooks · PubMed-direto conforme (Q1=23/Q2=2) · reconciliação roadmaps (THESIS_ROADMAP.md canônico Y0; v6→v7 colisão corrigida) · COST-DECOMP como template-de-cotação (10 drivers; preço=como-DOI) · canon 42 achados (F-40/41/42) · memória id17 atualizada
ESTADO: gates P1+P2 0/0 · AST 6/6 · PR#2 (paper-v6) completo: manuscrito P2 md+PDF (ACP C054) + guardian2 + scout · 54/38/48
PRÓXIMO: (autora) PARTE2-V2-VALIDACAO + entrada-do-posicionamento-C-na-v6 (juntas) → merge PR#2 → BIORXIV P1 · (lab) GATEF dormant · (agente) fila vazia
ÂNCORA: main@67b2ee6 · paper-v6@d71b42e(+) · v3.0 · predições v1.0


/RECAP 2026-08-28 (merge) — PR #2 MERGED em main@a01f8c2: **TESE COMPLETA EM DUAS PARTES** (P1=v5/release v3.0; P2=v6=ACP com PRODUTO FINAL + validação expressa da autora registrada). Gates 0/0 · AST 6/6 · fila agente vazia · restam: BIORXIV (autora) + GATEF (lab, dormant)

/RECAP-RETRO 2026-08-29→30 (reconstruído do git em 30/08 — não-contemporâneo; fecha P-004)
FEITO (29/08 main): RENAME ACP→ETRIZAÇÃO (validação expressa da autora) · documento de tese enriquecido (Cap.1-2, Apêndice B mapa-da-lógica, §5.1-bis achado único+argumento filosófico) · VALIDAÇÃO INTEGRAL 38/38 (6 dimensões × skills scientific-*) · concordância plano-vs-entrega 44/44 · PDF FINAL 170KB · ADENDO-FILOSOFICO resolvido por integração
FEITO (29-30/08 branches): executor batches 1-6 + verificação CrossRef + D-01/D-02/D-03 fechados · gap-mapper v1/v2 (4 parâmetros validados por literatura independente) + ACTION_PLAN_CROSS_SPECIES (diretriz da autora) · otimizacao FULL.tex 1506L + TESE-FICHA-TEMPLATE
ESTADO à época: gates 0/0 (hook bloqueante ativo) · registro 54/38/48 · main 9ad4428

/RECAP 2026-08-30 — Sessão AUDITORIA+GARANTISTA (local+remoto)
FEITO: captura total de auditorias locais (AST/gates/TODO-registry/worktrees) e remotas (API: branches/PRs/tags/releases/CI=0-runs) → AUDIT_CAPTURE_2026-08-30.md (9 divergências validadas D1-D9) · PENDENCIAS.md ledger mestre (22 itens; 18 abertos; 0 agente-planejada sem {{DEFER}}) · scripts/pendencias_check.py = A9 embutido no ast_check.py + pre-commit (planejada-sem-defer bloqueia commit; evidência-ausente bloqueia; drift de marcador bloqueia) · portabilidade skills corrigida (env>repo-local>/workspace>~/.agents) → AST 8/8 VERDE neste ambiente · higiene: 3 marcadores obsoletos removidos (ETRIZACAO-APLICAR/PUBMED-DIRECT/Q3-Q5-EXEC) · RECAP-RETRO anexado acima
ESTADO: gates P1+P2 0/0 · AST 8/8 (A2-A9) · ledger: 5 agente-deferidas (P-001 sweep-taxas, P-002 xspecies-θ, P-015 cost-decomp, P-018 batch6, P-019 fixfig1-decisão) · 3 não-mergeadas (executor/gap-mapper/otimizacao) · git local INOPERANTE (objetos placeholder; fetch falha em pack — D9) — trabalho em working tree; commit/push via API GitHub (cred store existe) ou ambiente original
PRÓXIMO: (agente) P-001 sweep composição taxas ±50% → JSON→N-fatos→gate · depois P-002 xspecies | (autora) P-007 BIORXIV · P-008 TESE-FICHA · P-009 OK anexos→merge P-020 · P-010 kit RML | (executor/lab) P-012/13/14 · GATEF dormant
ÂNCORA: remoto main@9ad4428 + working tree local 30/08 (sem commit local — D9) · tags v1.0/v3.0/v6.0 · predições travadas v1.0

/RECAP-ADD 2026-08-31 — CI GATED LIVE (continuação da sessão garantista)
FEITO: workflows no GitHub — `ast-quality-gate.yml` (A2-A9 bloqueante em todo push/PR a main) + `pdf-version-audit.yml` reescrito como pipeline **gated** (job ast-gate → job version-pdf: pandoc+xelatex; PDF só nasce sob AST VERDE; versão datada commitada por ci-audit-bot) · deploy via Git Data API (4 commits: ef1eb30 ledger+A9+docs · c194165 scripts/validators — faltavam NO remoto, causa dos FAILs A4-A8 · 7027e71 xelatex · bc9bbe4 fix YAML dois-pontos · 319822b ci_audit.sh versionado) · causa-raiz dos FAILs: (1) validators só-locais, (2) pdflatex não compila Unicode θ/×/≥ (→xelatex, mesmo papel do tectonic), (3) dois-pontos em name: quebrou parse (run órfão 0-jobs) · CI estava 0-runs desde sempre — agora VERDE: run 33367843020 (AST) + 33367843021 (PDF+audit; bot-commit 3eb9f2b 'PDF versionado 20260831-072054 criado sob gate AST VERDE') · contorno da instabilidade de edge do GitHub (/git/* 404 intermitente): clone raso ~/q3ci + push normal (via de commit canônica daqui em diante) · billing-privado NÃO bloqueia gates leves
ESTADO: main@3eb9f2b · AST CI VERDE ×3 consecutivos · PDF pipeline VERDE ×1 · A9 garantista vigente em 3 superfícies (pre-commit local, ast-quality-gate CI, ci_audit.sh)
PRÓXIMO: idem /RECAP 30/08 (P-001 sweep S3 primeiro) · pendência nova menor: watcher de runs (badge no README — opcional)
ÂNCORA: main@3eb9f2b · runs 33367843020/21 · predições travadas v1.0

/RECAP-ADD 2026-08-31 (tarde) — PARTE 3 PLANEJADA + MEMÓRIA EMPURRADA
FEITO: leitura INTEGRAL do worktree gap-mapper (branch próprio @e7a2976: GAP_MAPPER_REPORT + V2_EXHAUSTIVE 18 papers GRADE + ACTION_PLAN_CROSS_SPECIES — 8 validações independentes, 0 contradições não-resolvidas, GAP-1 estrutural) · trajetória documentada (F-39→evolução3→gap-mapper v1/v2→diretriz da autora→ACTION_PLAN) · **PLAN_PARTE3_CROSS_SPECIES.md** criado (paper/guardian/): §0 memória-de-continuidade · §1 trajetória · §2 inventário por espécie · §3 Fases 0-4 com Cenários A/B/C + C0 pré-registrados · §4 TODO×skills (P-023 extração c/ proveniência · P-024 runner multi-species parity-C0 · P-025 análise θ*+IC · P-026 síntese+gates+PR) · §5 hooks CI/CD por branch-commit com retorno e controle de task · §6 mermaid · ledger ampliado 22→26 itens (9 agente-planejadas TODAS com DEFER; A9 PASS) · ast-quality-gate.yml agora dispara em push main+gap-mapper+executor+otimizacao (branch sem ledger = vermelho até reconciliar — Fase 0 do plano) · push de memória: guardian+PENDENCIAS+PLAN+workflow → remoto via ~/q3ci
ESTADO: main avança com PARTE 3 documentada antes de executada (anti-hindsight) · CI: gates por branch ativos · P-001 (S3 sweep) segue primeiro da fila
PRÓXIMO: (agente) P-001 S3 → Fase 0 sync gap-mapper←main → P-023..26 | (autora) P-007/8/9/10 idem | retorno: runs CI + artifacts ast-report
ÂNCORA: este commit + branch gap-mapper @e7a2976 (fonte) · PLAN_PARTE3 é o contrato de execução · predições v1.0 intocadas

/RECAP-ADD 2026-08-31 (noite) — CHECKPOINT DE RETORNO CLOUD (sessão interrompível de propósito)
CONTEXTO: **P-001 S3 rodando NO CLOUD** (GHA run 33459375823 · workflow `s3-sweep.yml` · seed 9/11 p1 commitado · driver resumível via artifact `s3-checkpoint`). Fase 0 OK (gap-mapper@edd2361 sincronizado; hooks por branch ATIVOS). Harvester pronto (`experiments/s3_harvest.py`). Dados p1 até agora: BASE 0.819 · N±50% 0.791/0.884 · C_Kt 0.801/0.859 · C_Kr 0.819/0.819 · C_Kc_x0.5 0.809 — TUDO na banda 0.79-0.88mm (sinal forte de C1-insensível, aguardando p2 clock-matched p/ veredito).
ATIVIDADE AO RETORNAR (ordem exata):
1. run concluída? → pull main → `experiments/ws_9_results/ws_9_v5_sweeps_S3.json` (bot-commit). [timeout/falha → re-dispatch s3-sweep (retoma do artifact); API edge-404 → usar `/actions/runs?per_page`]
2. `python3 experiments/s3_harvest.py` → veredito C0-C3 + N049-N054 no consistency_manifest
3. canon F-43 (ZOOM 3, binding C051·E032) · AUDIT_NOTES §S3 (reprodução incidental S2: c20k2=0.819 no log local)
4. ledger: P-001→FECHADA (evid. JSON) · P-002 re-prioridade pelo veredito (C1→confirmação barata; C2→prioridade-1)
5. /RECAP final + push (~/q3ci main) → AST 8/8 + CI verde
6. PRÓXIMO DA FILA: **P-023** (extração params/espécie c/ proveniência — Fase 1 da PARTE 3)
COMPUTE-MATRIX (decisões cloud — travadas): **GHA** = via ATUAL p/ sweeps [SIM] (billing OK p/ jobs leves; script desenhado p/ GHA) · **CF Workers** = REJEITADO p/ o motor (port V8/Pyodide quebraria contrato motor-EXATO/paridade C0 + limites CPU 30s-5min) — tokens DISPONÍVEIS `~/.cloudflare/{token,mesh-token}` p/ papéis futuros de ORQUESTRAÇÃO/agendamento (não compute) · **GPU** (Modal/RunPod) = SÓ p/ motor v6 pós-REPARAM (§4) com parity-gate PRÓPRIO — predições travadas v1.0 JAMAIS rodam em motor portado; chave GPU NÃO existe no projeto → solicitar à autora SE/QUANDO aprovado
ÂNCORA: main@fc78e58 · run 33459375823 · seed 9/11 no repo · predições v1.0

/RECAP 2026-09-01 ~02:00 — P-001 S3 EXECUTADO E FECHADO (ciclo cloud completo)
FEITO: **P-001 CONCLUÍDO em computação híbrida local+cloud** (9/11 p1 local c/ checkpoint-resume anti-phantom-killer; 2 p1+10 p2 clock-matched+2 H no GHA run 33459375823; artifact 9783045928; finalize local instantâneo) → `experiments/ws_9_results/ws_9_v5_sweeps_S3.json` · **VEREDITO C2: GAP-1 MATERIAL** (critérios pré-registrados do SKILL_SCOUT_S3 aplicados sem renegociação): C0 paridade EXATA cross-ambiente (2.828/144.02) · paridade-gerações: Kt×2 e uniforme×2 ROMPEM κ=2 (escape saturado no domínio ≥2,83mm = limite inferior) · Kr/Kc ±50% insensíveis (±1-3%) · paridade-calendário: tudo contém (0,79-0,88mm) ⇒ **contenção depende da razão reação/difusão (Damköhler), não só de θ*** · C3 hierarquia seed-mass preservada no extremo (MV2 2.828 > MV1 1.144) · N049-N054 no consistency_manifest (54 N-fatos) · canon F-43 · AUDIT_NOTES §S3 (incl. falso-positivo documentado R0-NBIND-N050: zero ocorrências de 245.3 em 6 superfícies) · reprodução incidental S2 (c20k2=0.819) · ledger P-001→FECHADA · **P-002→PRIORIDADE-1** · workflow s3-sweep fixado (fetch+rebase antes do push) · AST 8/8 VERDE
ESTADO: gates P1 0-BLOCKED (1 AMEND falso-positivo documentado) · P2 0/0 · registro 54/38/54 · ledger 26 itens (4 fechadas) · CI verde (AST+PDF) · checkpoint RETORNO-CLOUD superado
PRÓXIMO: **P-023** (Fase 1 PARTE 3: extração params/espécie com proveniência — hamster primeiro: Telling 1995 + Castilla 2008; elevar Corridon 2026→E039) → P-024 runner multi-species → Cenários A/B/C
ÂNCORA: este push + run 33459375823 + artifact 9783045928 · θ/*=0,333 v1.0 COMPARADO jamais retreinado · predições v1.0

/RECAP-ADD 2026-09-01 ~03:30 — AUDITORIA CRÍTICA DE DADOS (skill scientific-critical-thinking, papel analista)
FEITO: `paper/guardian/S3_DATA_AUDIT_CRITICA.md` — forense do dataset S3 (E-S3-01..08) + auditoria GRADE do inventário por espécie (pré-P-023) + adequação metodológica · **achados centrais**: (1) escapes são DADOS CENSURADOS no canto do grid (2,828mm — mesmo valor do S1-exp1 histórico; R=limite inferior; veredito C2 mantém, magnitude além do flag é indefensável); (2) decomposição extrema: Kt sozinho controla relógio (t2 ratio 0,49-2,10) E contenção — Kr/Kc ≈ nulas (confirmações independentes: J≡C_Kt em 0,859; N≡J_x0.5 em 0,637) ⇒ **identificabilidade do P-023 reduz-se a Kt-scale+relógio por espécie** (E-S3-02 mitigada pelo próprio dado); (3) não-padrões: assimetria Kc 5,5%/3,8%, cap de matching N_x2 (−1,6% gerações), MV2 censurado na hierarquia, C50 absorvido pelo regime saturado (não-identificável nestas condições → A6-wet deve varrer κ não C50); (4) inventário por espécie: 1/6 pronto-ponto (camundongo), 1/6 banda (humano — Corridon é PrP-humano-em-fundo-murino), 4/6 exigem proveniência; levedura = ortogonal ao Damköhler · recomendações travadas p/ P-024 (escape-flag, pareamento duplo, observáveis de massa, braços log-espaçados, humano=banda ×{0,5,1,2}) e P-023 (banda+fonte por parâmetro; E039 Corridon antes de uso) + **pré-registro proposto: Kt_hamster≥2×murino ⇒ κ=2 falha no braço hamster** · canon F-43 anotado com censura
ESTADO: idem /RECAP anterior + auditoria pendente de revisão da autora (recomendações 1-3 = pré-condições de validade do P-024)
PRÓXIMO: (autora) validar recomendações da auditoria → travar spec P-024 | (agente) P-023 pós-validação · predição hamster a pré-registrar
ÂNCORA: main@7b20ed1 + este push · dataset S3 íntegro (censuras documentadas)

/RECAP 2026-09-01 ~05:30 — PARTE 3 FASES 1-3 CONCLUÍDAS (P-023/24/25 FECHADAS)
FEITO: **P-023** species_params.json (grupos A-D, banda+fonte; predição hamster pré-registrada no JSON) + análise de parametrização (correlação global fraca / local loop-β2-α2 + contextual expressão; bolso G127 100% conservado) + **E039 Corridon elevada** (39 fontes 0/0) + sequências PrP 5 espécies verificadas NCBI + matriz identidade BLOSUM62 (biopython; scikit-bio sem wheel py3.14) · **P-024** driver+workflow GHA-matrix (defs pré-registradas ANTES: escape-flag 2,80 · κ_min R≤0,90 · θ\*=1/(1+κ_min) · pareamento ao crescimento livre · C0/job) → **4/4 success** (run 33470363167) · **P-025** análise: **CENÁRIO B** (θ\* central 0,333-0,400, razão 1,20≤2×) + regra emergente κ_req↔Kt (1→1,5 · 2→2 · 3→3 · 4→8 superlinear; hamster-hi θ\*=0,111) + **θ\* horizon-dependente** (3 defs: livre-próprio/calendário-t5 contêm vs S3-base-tratado escapa) + **predição hamster REFUTADA sob def P-024 (0,659mm κ=2/Kt=2) — reportada sem renegociar def** + N055-N059 (59 N-fatos) + canon F-44 · COMPUTE_EVAL medido (local 229s vs GHA 72s=3,2×; CF=orquestração-only; GPU/SaladCloud=só-v6-pós-REPARAM; sem chave GPU no projeto)
ESTADO: AST 8/8 · gates 0-BLOCKED · registro 54 claims/39 fontes/59 N-fatos · ledger 26 itens (7 fechadas) · CI verde contínuo (1 episódio vermelho por drift meu — corrigido e documentado; hook provou-se contra o operador)
PRÓXIMO: **P-026** — síntese PARTE 3 (Cenário B + regra de dose + horizon-dependence) → gates finais → PR gap-mapper→main (merge com PLAN_PARTE3/P023-25 docs) → /RECAP de fechamento da Parte 3
ÂNCORA: main@9b669be+ · run 33470363167 · JSONs p024\_{mouse,human,hamster,vole} · θ\*/*=0,333 v1.0 intocada (comparada sob defs declaradas)

/RECAP 2026-09-01 ~06:40 — **PARTE 3 FINDA: PR#3 MERGED (661e77e) — tese em TRÊS partes completas**
FEITO: THETA_STAR_EXPLAINED.md (θ\* documentado p/ banca: intuição → definição → 5 funções → o que NÃO é → linhagem v1.0→F-44) · PARTE3_SINTESE.md (veredicto formal Cenário B + integração programática + invariantes) · gates finais AST 8/8 · **PR #3 gap-mapper→main criado→CI ast ✓✓→MERGED** (autorização da autora: guardar→validar→merge) · ledger: **P-002/P-022/P-026 FECHADAS** (10 fechadas; 3 agente-planejadas restantes: P-015 COST-DECOMP · P-018 batch6 · P-019 fixfig1 — todas com DEFER)
ESTADO: registro 54 claims · 39 fontes (E039) · 59 N-fatos · canon 44 achados (F-43/F-44) · CI verde contínuo · branches ativas remanescentes: executor (merge condicionado a verificação claim-a-claim P-003) e otimizacao (condicionado a OK da autora P-009) · predições v1.0 intocadas
PRÓXIMO: (autora) P-007 BIORXIV · P-008 TESE-FICHA · P-009 OK-anexos→merge otimizacao · P-010 kit RML | (agente, se GO) P-003 verificação claim-a-claim dos 88 candidatos→merge executor · P-015/18/19 deferidas | G0-wet permanece o gate biológico
ÂNCORA: main@661e77e (merge PR#3) · releases v1.0/v3.0/v6.0 · arco completo: auditoria→scout→cloud-matrix→harvest determinístico→síntese→merge — a etrização da PARTE 3 documentada ponta-a-ponta

/RECAP 2026-09-01 ~07:50 — CICLO TOPOLÓGICO P-003→P-021 FECHADO + RATCHET
FEITO: **P-003 FECHADO** — verificação claim-a-claim INDEPENDENTE do agente (esummary + title-overlap: 7 PMID-verificados 0,8-1,0 · **0 mismatch**; +10 DOI-exatos herdados crossref-executor c/ proveniência) → **E-registry 39→56 fontes (E040-E056)** · validadores 0/0 · pool restante documentado (14 fuzzy + 16 URL exigirão identifier resolvível — regra) · AUDIT §P-003 · **P-021 FECHADO** — **PR#4 executor→main MERGED @d263761** (ast ✓; candidatos batches 1-6 + otimizacao docs integrados) · **RATCHET de qualidade**: piso AST A5 elevado (54,38,48)→**(54,56,59)** — progresso virou invariante (regressão de registro agora BLOQUEIA CI) · reflexão de decisões registrada (cloud medido 3,2× · checkpoint-resume · defs pré-registradas · bandas≠pontos · A9 contra o operador 2× · PR-gated merges)
ESTADO: AST 8/8 (A5 ratcheted) · ledger 26 itens (**12 fechadas** · 13 abertas · 3 agente-deferidas) · registro **54 claims · 56 fontes · 59 N-fatos** · branches: executor/gap-mapper MERGED; restam otimizacao (condicionada P-009) e fix/fig1 (P-019, decisão da autora) · CI verde contínuo
PRÓXIMO (topológico): **P-015 COST-DECOMP** (única agente-acionável restante: tabela suplementar EN+PT gated + paridade + re-gate + PDFs) · P-018 segue deferido (identifiers) · P-019/externas aguardam autora/lab
ÂNCORA: main@d263761+ · PRs #3/#4 merged · piso A5=54/56/59 travado no código

/RECAP 2026-09-01 ~09:00 — P-015 FECHADO: FILA DO AGENTE VAZIA
FEITO: **P-015 COST-DECOMP fechado** — Tabela Suplementar S1 nos manuscritos EN+PT (10 direcionadores; quantidades com fonte protocolar; preços deliberadamente ausentes — só via cotação datada/assinada pelo parceiro; regra preço-como-identificador preservada) · TODO COST-DECOMP removido das 2 superfícies (resolver=remover; A9: 8 marcadores vivos) · limitação 15 reescrita honestamente ('decomposed structurally, prices pending quotation') · paridade de tags EN=PT · gate P1: findings=10 BLOCKED=0 **AMEND=1 (só o fantasma N050 documentado)** · R2-ASSUM: 4 flags novos da tabela κ↔µM → rotulados ilustrativos → 0 · AST 8/8 · CI verde @f3e9ba7
ESTADO: **13/26 fechadas · fila agente VAZIA** (restam 2 deferidas: P-018 identifiers + P-019 decisão-autora) · tudo o mais aguarda autora (P-007/8/9/10), lab (P-011), executor-externo (P-012/13/14) · registro 54/56/59 com piso ratcheted
PRÓXIMO: (autora) BIORXIV · TESE-FICHA · OK-anexos→merge otimizacao (PR#5 pronto p/ criar) · kit RML · decisão fixfig1 | (lab) GATEF dormant | registro contínuo via A9/CI
ÂNCORA: main@f3e9ba7 · tese 3 partes + S1 suplementar · predições v1.0 intocadas

/RECAP 2026-09-01 ~11:30 — TESE v2: PARTE 3 INTEGRADA + REMEDIAÇÃO ESTRUTURAL + PIPELINE ABNT (P-027)
FEITO: **PR#5 tese-v2-parte3 MERGED @01ef9b4** — §4.7 validação multi-espécie na tese com claims C055-C057 (hashes norma skill) + binding N055-059 · achados integrados em 5.1/6.2/OE3/H2 · **limitação 9 da Parte 1 emendada EN+PT (achados presentes nas DUAS partes)** · SUMÁRIO atual (§4.7+Apêndice B+56 fontes) · duplo-índice MORTO (--toc CI removido; SUMÁRIO manual=fonte) · tabela-M reordenada+condensada · refs [39]-[56] ABNT do manifest · auditoria audit\_claims: 0 issues novos (4 não-pareados PRÉ-EXISTENTES C032/C046; divergências documentadas decálogo #8) · **PIPELINE ABNT NBR 14724** (preamble 3-2cm/12pt/1,5/recuo-1,25/nº-pág-sup-dir + workflow tese-abnt; **tese\_v2\_ABNT.pdf 171KB SUCCESS @e6c052f** — Sumário único ✓ · §4.7 ✓ · C055×5 ✓) · YAML-trap do dois-pontos pegou 2× (fixado; lição registrada)
ESTADO: gates P2 0/0 · P1 0-BLOCKED · AST 8/8 · CI: ast✓+abnt✓ · ledger 27 itens (14 fechadas) · registro 58 claims/56 fontes/59 N-fatos
PRÓXIMO: (autora) validação visual do PDF ABNT + ficha catalográfica no corpo (template pronto) + BIORXIV/TESE-FICHA/P-009/kit-RML · (agente) nada na fila — 2 deferidas (P-018 identifiers · P-019 decisão)
ÂNCORA: main@e6c052f · PRs #3/#4/#5 merged · tese = 3 partes + §4.7 + S1 + ABNT-PDF sob CI

/RECAP 2026-09-01 ~13:20 — EDIÇÃO ALFA CLÍNICA TAGUeada (tese-v2.1-alfa) — P-028
FEITO: camada pedagógica na tese (**garantia de leitura por qualquer médico**): NOTA DE LEITURA PARA CLÍNICOS (5 perguntas: que doença/que ideia/que evidência/que resultado/que promessa NÃO faz + mapa de símbolos em linguagem leiga) · openers 'Em linguagem clínica' nos núcleos §3.2 (equações) e §4.7 (multi-espécie) · LISTA DE SIGLAS completa (θ\*/θ\_obs/κ/Kt/Damköhler/PrP^C-PrP^Sc/RT-QuIC/DN) · **Figura 4** auditável (matplotlib dos JSONs p024 no CI — Termux não compila matplotlib; compute-matrix respeitada) · **AVALIACAO\_ALFA** via scholar-evaluation (developmental, 7 critérios com evidência-rastreável: C2/C4/C5/C6=4 · C1/C3/C7=3 c/ opções de melhoria não-prescritivas; SEM julgamento de aceitação; limitação da conformidade schema-máquina documentada) · gate P2 voltou a 0/0 (rótulo ilustrativo κ↔µM nas siglas — R2-ASSUM pegou 4×, corrigido) · **CI 3×verde** (ast + abnt-c/Figura4 + pdf-audit) · **race de bot-commits corrigido** (fetch+rebase no pdf-version-audit — mesma classe dos outros workflows) · **tag tese-v2.1-alfa** publicada
ESTADO: main@901fa60 · ledger 28 itens (15 fechadas) · registro 58 claims/56 fontes/59 N-fatos · frentes alfa remanescentes (não-bloqueantes, da avaliação): opener §2.4 · verificação visual do PDF com Fig.4 · resumo-1-página
PRÓXIMO: (autora) validar visualmente o ALFA (PDF ABNT + Fig.4) → decidir beta ou ajustes · BIORXIV/TESE-FICHA/P-009/kit-RML/P-019 idem · (agente) fila vazia (P-018/P-019 deferidas)
ÂNCORA: tag tese-v2.1-alfa @901fa60 · PRs #3/#4/#5 · arco completo auditoria→cloud→síntese→merge→remediação→alfa sob CI

/RECAP 2026-09-01 ~15:30 — CONSELHO DE VALIDAÇÃO ALFA (treatment-plans + Mind Council)
FEITO: **lente treatment-plans** aplicada (6 exigências do mindset clínico mapeadas contra a alfa: proveniência ✅ mais-forte-que-clínica · metas/monitoramento dispersos ⚠️ · shared-decision ausente ⚠️ · handoff-com-dono fora do texto ⚠️ · aviso-visível ausente ⚠️ · nunca-inferir isomórfico ✅) · **Mind Council 6 arquétipos** (Empath/Empiricist/Pragmatist/Ethicist/Contrarian/Outsider — cada um discordando; documento CONSELHO\_ALFA\_VALIDACAO.md): convergências = aviso clínico padronizado + resumo-1pág/rota-10min + tabela acompanhamento-previsto[SIM] + link dossier-parceria; **tensão central = otimizar p/ leitor vs. p/ agente(aliado)**; ponto-cego coletivo = público-alvo (geral vs. especialista) → decisão da autora; pergunta-para-levar: *qual a ÚNICA ação que o médico deve querer tomar após 10 min de leitura?* · **4 complementos implementados** na NOTA (caixa ⚠️ PROGNÓSTICO[NIM] · gancho primeira-linha doença · resumo-1pág c/ rota NOTA→Fig4→§6.2→Cap7 · tabela acompanhamento + link G0\_UNLOCK/outreach sem promessa) — fronteiras da skill respeitadas (documentação de desenho, nunca conduta) · gates P2 0/0 · AST 8/8 · CI 3×verde (race fetch+rebase estendido ao tese-abnt — classe fechada nos 3 workflows)
ESTADO: alfa+conselho no main (6a2eb32) · frente-beta formalizada: médico-como-aliado + público-alvo + opener §2.4 + verificação visual PDF/Fig.4 (pendências da autora)
PRÓXIMO: (autora) decidir beta (público-alvo + call-to-action parceria) · validar PDF ABNT visualmente · BIORXIV/TESE-FICHA/P-009/kit-RML · (agente) fila vazia
ÂNCORA: main@6a2eb32 · tag tese-v2.1-alfa (complementos pós-tag; beta re-tagueará) · CONSELHO\_ALFA\_VALIDACAO.md como registro da deliberação

/RECAP 2026-09-01 ~21:05 — SESSÃO M3.1-2 (P-030): U5+U6+U7 FECHADOS + PAPERSPINE BRAÇO-B EXECUTADO
FEITO: **U5** Fig.5 escada-de-dose (`make_fig5_doseladder.py` auditável lendo SÓ m31_u1u2.json; CI tese-abnt como Fig.4; data-JSON rastreio; divergência commit-67e06ae×JSON resolvida: JSON=canônico) · **U6** registro probatório: **GAP detectado e fechado — E057 Chen 2010 Kd 71nM VERIFICADO em fonte aberta (NCBI esummary + full-text PMC2924066: "apparent Kd of 71 nM" conferido)**; E058 cômputo próprio; claims C058-C060 (norm→sha256; binding 6-E; incerteza honesta high/moderate); N060-N065; validadores 0/0 (validate/consistency/references; audit_claims 0 erros novos); ratchet A5→(60,58,65); **AST 9/9 VERDE** (A1 local restaurado: fallback de fonte no ws_7_solver — pré-existente também no main) · **U7** PR#6 MERGED m31-dose→writing-v2-test (B4 alimentado c/ M3.1; validação M3→M2 §5; build-stage 4 artefatos) · **PaperSpine braço-B completo**: stages build→writing (tese_unificada 411L: M1-nota→base-comum→M3→M2-c/M3.1→métodos→validação→clínica→limitações→conclusões + refs [1]-[58])→integrity (ALL CLEAN)→latex (main.tex latex_guard 0-erros; PDF xelatex no CI)→word (docx TNR; word_guard PASS exc. TODO-legítimo)→final-audit V4 3×PASS (contribution/results-validation/reviewer-audit 15 objeções) · **2 desvios documentados** (cota citation-bank 3×80% = norma venue-journal × E-registro da casa — RECUSADA por anti-fabricação; quality-audit offline heurístico) · CI: AST-verde + Unified-Thesis-Build (PDF/docx versionados) · A-vs-B planilha pronta p/ autora
ESTADO: AST 9/9 · registro 60/58/65 · V4 3×PASS · CI 2×verde · P-030 FECHADA · P-029 EXECUTADA_NAO_MERGADA (adoção=autora) · predições v1.0 intocadas
PRÓXIMO: (autora) decidir A-vs-B (A_VS_B_AVALIACAO.md) + ficha TESE-FICHA (P-009) + pendências fixas idem · (agente se adotar-B) guardian perfil-part2 na tese unificada + PR→main c/ CI
ÂNCORA: m31-dose@98e7c02 · writing-v2-test@5ef4bba+CI · PR#6 · E057/PMID 20576610
/RECAP 2026-09-01 ~18:40 — SESSÃO FECHADA: M3.1 NASCEU + PAPERSPINE 1-6 + HANDOFF NOVA SESSÃO
FEITO: **M3.1 (a primeira dose calculada) nasceu sob garantista** — avaliação crítica pré-registrada (elo fractal: cadeia κ→massa nunca fechada com incerteza; Kd-proxy=Aβ; Kt-paciente=desconhecido➞escada; vetor-primário=A6) · método U1-U7 com critérios-de-aceitação ANTES-de-computar · skill-scout (uncertainty-and-units + pkpd-modeling + incremental; avaliador critical-thinking) · **local-na-árvore: branch m31-dose filho-de-main → PR ao writing-v2-test/B4** · **U1+U2 executados**: MW=22,83 kDa das NOSSAS sequências + cadeia A6 banda-GUM (Kt1→0,02-1,9 · Kt2→0,03-2,6 · Kt3→0,05-3,9 · Kt4/pior→0,2-10,3 µg/depósito; redose ≤7d) — largura ~2 ordens dominada pelo Kd-proxy = ACHADO (G0-A6 fecha) · **PaperSpine stages 4-6 ✓** (motivação M4-DA-AUTORA: M1-nota-à-banca→M3→M2 + **validação M3→M2 com cronologia honesta**: M3 fundamenta/transfere, não gera; números confrontados; única assimetria=horizonte-declarado) · blueprints B0-B9 + matrix R0-R9 · **HANDOFF nova sessão** (M31_SESSAO2_PLANO.md @m31-dose/33f2e9f): ordem-da-autora = **scientific-writing/AST primeiro** (U5 Fig.5 + U6 claims C058+/N-fatos/gates) **→ retomar paper-spine** (6-writing→8→12) → integração → A-vs-B (decisão=autora) · ledger P-030
ESTADO: main CI-verde · branches: m31-dose@33f2e9f (U1-U2+plano) · writing-v2-test@67298b2 (stages 1-6) · registro 58/56/59 · PaperSpine 4/12 gates
PRÓXIMO (NOVA SESSÃO): seguir M31_SESSAO2_PLANO §2 (U5→U6→U7→paper-spine 6→8→12) · (autora) pendências fixas idem (BIORXIV/TESE-FICHA/P-009/kit-RML/P-019/beta)
ÂNCORA: m31-dose@33f2e9f · writing-v2-test@67298b2 · predições v1.0 intocadas · a banda é o achado até G0-A6

/RECAP 2026-09-01 ~22:00 — ADOÇÃO WRITING-V2 (decisão da autora: "merge B-vencedor + A-vencedores")
FEITO: métrica-2 do protocolo EXECUTADA pelo agente — guardian R0-R3 perfil-part2 na tese unificada: 1ª rodada FAIL 21-BLOCKED/30-AMEND (classe contrato-de-tag: over-tagging de assumptions κ↔µM; canon ausente) → correção 1 iteração → **PASS 0/0** (mesmo patamar do A; relatório guardian_report_unified_test.md) · avaliação A-vs-B entregue (matriz 10 critérios: B 6 · A 2 · empate 1; os 2 de A portáveis) · **DECISÃO DA AUTORA: adotar merge** → executado: Cap.7 camada-clínica-alfa INTEGRAL do A portada (+ adições B: dose-A6 na pergunta-4, Fig.5 na rota-10min) · EN companion da edição unificada (novo-conteúdo íntegro; Partes 1-2 EN referenciadas; paridade tags) · merge main→braço resolvido (paper_rewriting_output=braço; ledger união) · **PR#7 MERGED @6194190 + tag writing-v2-adopted** · P-029 FECHADA (adoção) · AST 9/9 no main (ratchet 60/58/65) + CI AST dispatchado
ESTADO: main = tese unificada ADOTADA (B-espinhaço + A-campos) · registro 60/58/65 · co-edição ABNT intacta · predições v1.0 intocadas · P-029/P-030 FECHADAS
PRÓXIMO: (autora) ficha TESE-FICHA P-009 + leitura da edição unificada (paper/pdf/tese_unificada_*.pdf) + pendências fixas (BIORXIV/kit-RML/P-019/beta) · (agente) recorte-artigo do achado da banda p/ periódico quando autora abrir
ÂNCORA: main@6194190 · tag writing-v2-adopted · PR#7 · guardian_report_unified_test.md
